Early onset of endocrine abnormalities in β-thalassemia major in a developing country

Journal of Pediatric Endocrinology and Metabolism

Volumn 13, Issue 6, 2000, Pages 651-656

  Gulati, R ^a   Bhatia, Vijayalakshmi ^a   Agarwal, S S ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Thalassemia major; Hormone; India

Indexed keywords

GROWTH HORMONE; HYDROCORTISONE; SOMATOMEDIN C; THYROID HORMONE;

ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOCRINE DISEASE; FEMALE; GLUCOSE TOLERANCE; GROWTH; HORMONE DETERMINATION; HUMAN; HYPOGONADISM; INDIA; INFANT; IRON CHELATION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PUBERTY; SHORT STATURE; THALASSEMIA MAJOR;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; BETA-THALASSEMIA; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; ENDOCRINE GLANDS; FEMALE; GLUCOSE INTOLERANCE; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOGONADISM; INFANT; INSULIN-LIKE GROWTH FACTOR I; MALE; PROSPECTIVE STUDIES; PUBERTY; THYROXINE;

EID: 0033932447     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Oerter KE, Kamp GA, Munson PJ, Nienhuis AW, Cassorla FG, Manasco PK. Multiple hormone deficiencies in children with hemochromatosis. J Clin Endocrinol Metab 1993; 76: 357-361.
2. Costin G, Kogut MD, Hyman CB, Ortega JA. Endocrine abnormalities in thalassemia major. Am J Dis Child 1979; 133: 497-502.
3. Masala A, Meloni T, Gallisai D, Alagna S, Rovasio PP, Rassu S, Milia AF. Endocrine functioning in multi-transfused prepubertal patients with homozygous β-thalassemia. J Clin Endocrinol Metab 1984; 58: 667-670.
4. Vannasaeng S, Ploybutr S, Visutkul P, Tandhanand S, Suwanik R, Wasi P. Endocrine function in thalassemia. Clin Endocrinol 1981; 14: 165-173.
5. Grundy RG, Woods KA, Savage MO, Evans JPM. Relationship of endocrinopathy to iron chelation status in young patients with thalassemia major. Arch Dis Child 1994; 71: 128-132.
6. Agarwal MB, Shah S, Vishwanathan C, Rajadhyaksha G, Bhave AA, Dube SR, Billa V, Malkan G, Bajan K. Thyroid dysfunction in multi-transfused iron loaded thalassemia patients. Indian Pediatr 1992; 29: 997-1002.
7. Jain M, Sinha RS, Chellani H, Anand NK. Assessment of thyroid functions and its role in body growth in thalassemia major. Indian Pediatr 1995; 32: 213-219.
8. Agarwal DK, Agarwal KN, Upadhyay SK, Mittal R, Prakash R, Rai S. Physical and sexual growth pattern of affluent Indian children from age 5 to 18 years of age. Indian Pediatr 1992; 29:1203-1268.
9. Agarwal DK, Agarwal KN. Physical growth of affluent Indian children (birth to 6 years). Indian Pediatr 1994; 31; 377-413.
10. Hamill PVV, Johnson CL, Reed RV, Roche AF. NCHS growth curves for children, birth-18 years. Hyattsville, MD: National Center for Health Statistics, Publication Number DHS 878-1650, 1977.
11. Rosner B, Prineas R, Loggie J, Daniels SR. Percentiles for body mass index in U.S. children 5 to 17 years of age. J Pediatr 1998; 132: 211-222.
12. Italian Working Group on Endocrine Complications in Non-Endocrine Diseases. Multicentre study on prevalence of endocrine complications in thalassemia major. Clin Endocrinol 1995; 42: 581-586.
13. Borgna-Pignatti C, De Stefano P, Zonta L, Vullo C, De Sanctis V, Melevendi C, Naselli A, Masera G, Terzoli S, Gabutti V, Piga A. Growth and sexual maturation in thalassemia major. J Pediatr 1985; 106: 150-155.
14. Caruso-Nicoletti M, De Sanctis V, Capra M, Cardinale G, Cuccia L, Di Gregorio F, Filosa A, Galati MC, Lauriola A, Melizia R, Mangiagli A, Massolo F, Mastrangelo C, Meo A, Messina MF, Ponzi G, Riola G, Ruggiero L, Tamborino G, Saviano A. Short stature and body proportion in thalassemia. J Pediatr Endocrinol Metab 1998; 11 (Suppl 3): 811-816.
15. Soliman AT, el Zalabany M, Amer M, Ansari BM. Growth and pubertal development in transfusion-dependent children and adolescents with thalassemia major and sickle cell disease: a comparative study. J Trop Pediatr 1999; 45: 23-30.
16. Wang C, Tso SC, Todd D. Hypogonadotropic hypogonadism in severe β-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy. J Clin Endocrinol Metab 1989; 68: 511-516.
17. Theodoridis C, Ladis V, Papatheodorou A, Berdousi H, Palamidou F, Evangelopoulou C, Athanassaki K, Konstantoura O, Kattamis C. Growth and management of short stature in thalassemia major. J Pediatr Endocrinol Metab 1998; 11 (Suppl 3): 835-844.
18. Bronspiegel-Weintrob N, Olivieri NF, Tyler B, Andrews DF, Freedman MH, Holland FJ. Effect of age at the start of iron chelation therapy on gonadal function in beta thalassemia major. N Engl J Med 1990; 323: 713-719.
19. Low LCK, Postel-Vinay MC, Kwan EYW, Cheung PT. Serum growth hormone (GH) binding protein, IGF-I and IGFBP-3 in patients with β thalassemia major and the effect of GH treatment. Clin Endocrinol 1998; 48: 641-646.
20. Gamberini MR, Fortini M, Gilli G, Testa MR, De Sanctis V. Epidemiology and chelation therapy effects on glucose homeostasis in thalassemic patients. J Pediatr Endocrinol Metab 1998; 11 (Suppl 3): 867-869.